ReachMD

Be part of the knowledge.™

Nephrology

193

LikeLikedUnlike

Episodes 1-15 of 36

What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
CME/CE
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
- Ellie Kelepouris, MD, FACP, FAHA
  Peer
- Stephen J. Greene, MD, FACC, FHFSA
  Peer
0.25 credits
What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?
CME/CE
What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
- Antoni Bayés-Genís, MD, PhD, FESC, FHFA
  Peer
- Ovidiu Chioncel, MD, PhD
  Peer
- Marco Metra, MD
  Peer
0.50 credits
Achieving Success in IgAN & FSGS
CME/CE
Achieving Success in IgAN & FSGS
- Siân Griffin, MD, PhD
  Peer
- Jürgen Floege, MD
  Peer
- Loreto Gesualdo, MD, FERA
  Peer
0.25 credits
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CE
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
- Thilo Krüger, MD, PhD
  Peer
- Steven Fishbane, MD
  Peer
- Lucio Manenti, MD, PhD
  Peer
0.50 credits
What’s the Consensus on Cardiorenal Protection for CKD in T2D?
CME/CE
What’s the Consensus on Cardiorenal Protection for CKD in T2D?
- Tessa Laubscher, MBChB, CCFP, FCFP
  Peer
- George L. Bakris, MD, FAHA, FASN
  Peer
- Mikhail Kosiborod, MD
  Peer
0.50 credits
Can We Do Better in IgAN?
CME/CE
Can We Do Better in IgAN?
- Jonathan Barratt, PhD
  Peer
- Annette Bruchfeld, MD, PhD
  Peer
0.25 credits
Applying Evidence to Practice: What Can We Learn from Recent Clinical Trials of IV Iron Use in HF?
CME/CE
Applying Evidence to Practice: What Can We Learn from Recent Clinical Trials of IV Iron Use in HF?
- Piotr Ponikowski, MD, PhD, FESC, FHFA
  Peer
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
  Peer
0.25 credits
Hyperkalemia: Is It Still a Challenge in 2023?
CME/CE
Hyperkalemia: Is It Still a Challenge in 2023?
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Patrick Rossignol, MD, PhD
  Peer
0.25 credits
KALMing the Itch: Improving QoL in Patients with CKD-aP
CME/CE
KALMing the Itch: Improving QoL in Patients with CKD-aP
- Joel Topf, MD
  Peer
- Kieran McCafferty, MD
  Peer
0.25 credits
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
CME/CE
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
- Jonathan Barratt, PhD
  Peer
- Donald E. Kohan, MD, PhD
  Peer
0.50 credits
Separating Fact from Fiction: The Realities of CKD-aP
CME/CE
Separating Fact from Fiction: The Realities of CKD-aP
- Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
  Peer
- Antoine Lanot, MD, PhD
  Peer
0.25 credits
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME/CE
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
- Mario Cozzolino, MD, PhD
  Peer
- Jan T. Kielstein, MD, FASN, FERA
  Peer
0.50 credits
Case-Based Management of AAV
CME/CE
Case-Based Management of AAV
- David Jayne, MD
  Peer
- Annette Bruchfeld, MD, PhD
  Peer
0.25 credits
3 Things You Need to Know About Calciphylaxis: Earlier Intervention, Current Treatments, and Emerging Therapies
CME/CE
3 Things You Need to Know About Calciphylaxis: Earlier Intervention, Current Treatments, and Emerging Therapies
- Smeeta Sinha, PhD
  Peer
- Sagar Nigwekar, MD
  Peer
0.25 credits
Don’t Let Hyperkalemia Get You Down When Potassium Goes Up in Your Patients with Heart Failure
CME/CE
Don’t Let Hyperkalemia Get You Down When Potassium Goes Up in Your Patients with Heart Failure
- Javed Butler, MD, MBA, MPH
  Peer
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Patrick Rossignol, MD, PhD
  Peer
0.25 credits

Program Chapters

Segment Chapters

Playlist:

Recommended